Relapsed/refractory large B-cell lymphoma
Clinical trials for Relapsed/refractory large B-cell lymphoma explained in plain language.
Never miss a new study
Get alerted when new Relapsed/refractory large B-cell lymphoma trials appear
Sign up with your email to follow new studies for Relapsed/refractory large B-cell lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental donor CAR-T therapy tested in lymphoma – trial halted early
Disease control Stopped earlyThis early-phase trial tested a new therapy called ATA3219, which uses immune cells from a healthy donor to attack cancer cells in people with relapsed or refractory B-cell non-Hodgkin lymphoma. The study aimed to check safety and see if the treatment works, but it was stopped ea…
Matched conditions: RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA
Phase 1 • Sponsor: Atara Biotherapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Experimental CAR t combo trial halted early – only 2 patients enrolled
Disease control Stopped earlyThis study tested whether adding an extra drug (ALLO-647) to standard chemotherapy before a special immune cell treatment (CAR T) could help adults with a hard-to-treat type of lymphoma. Only 2 people joined before the trial was stopped early. The goal was to see if the new combi…
Matched conditions: RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA
Phase 2 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC